Policy | October 14, 2024
CDSCO, NRAI meets WHO international standards for vaccine regulations
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Patalganga plant received zero observation from USFDA earlier
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Subscribe To Our Newsletter & Stay Updated
